Dr. Zheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1120 15th St
Augusta, GA 30912Phone+1 706-721-8623Fax+1 706-721-1459
Education & Training
- University of Nebraska Medical Center College of MedicineFellowship, Hematopathology, 2013 - 2014
- Medical College of GeorgiaResidency, Pathology-Anatomic and Clinical, 2009 - 2013
- Hebei Medical UniversityClass of 1986
Certifications & Licensure
- GA State Medical License 2015 - 2026
- NE State Medical License 2013 - 2018
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Hematology
Publications & Presentations
PubMed
- 39 citationsFrequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma.Mei Zheng, Anamarija M. Perry, Philip J. Bierman, Fausto R. Loberiza, Michel R. Nasr
Neuropathology. 2017-08-30 - 3 citationsA Paratesticular Serous Borderline Tumor in a Pediatric Patient With Proteus SyndromeZachary Klaassen, Patrick J. Fox, Lauren McLees, Mei Zheng, Suash Sharma
Urology. 2015-12-01 - 67 citationsPrimary leiomyosarcomas of the gastrointestinal tract in the post–gastrointestinal stromal tumor eraGitika Aggarwal, Suash Sharma, Mei Zheng, Michelle D. Reid, John H. Crosby
Annals of Diagnostic Pathology. 2012-12-01
Press Mentions
- Nuclear Expression of DDIT3 Distinguishes High-Grade Myxoid Liposarcoma from Other Round Cell SarcomasMarch 17th, 2021
- Comparative Analysis of ACE2 Protein Expression in Rodent, Non-Human Primate, and Human Respiratory Tract at Baseline and After Injury: A Conundrum for COVID-19 PathogenesisFebruary 24th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: